Arezoo Hosseini

miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4

Mohammad Reza Mohammad Hoseini Azar, Hamed Aghazadeh, Halgurd Nadhim Mohammed et al. · International Immunopharmacology · 2021 · 47 citations

Oncology, Medicine, Oxaliplatin Chemoresistance +9

Environmental risk factors for the incidence of cutaneous leishmaniasis in an endemic area of Iran: A GIS-based approach

Roghieh Ramezankhani, Arezoo Hosseini, Nooshin Sajjadi et al. · Spatial and Spatio-temporal Epidemiology · 2017 · 39 citations

Parasitic Disease, Endemic Area, Parasitic Protozoa +9

IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression

Tohid Gharibi, Arezoo Hosseini, Faroogh Marofi et al. · Immunology Letters · 2019 · 36 citations

Autoimmune Disease, Allergy, Il-21-producing T Cells +11

Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population

Vida Hashemi, Amir Salek Farrokhi, Asghar Tanomand et al. · Immunology Letters · 2018 · 35 citations

Inflammation, Rheumatology, Immunogenetics +14

Ruxolitinib attenuates experimental autoimmune encephalomyelitis (EAE) development as animal models of multiple sclerosis (MS)

Arezoo Hosseini, Tohid Gharibi, Adel Mohammadzadeh et al. · Life Sciences · 2021 · 30 citations

Autoimmune Disease, Medicine, Immunology +10